Search
for
Sort by
Research 121–150 of 1000+
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Isolation, Structural Elucidation and Therapeutic Potentials of Root of Cucurbita pepo
- Why would men use finasteride in 2005?
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Finasteride-its impact on sexual function and prostate cancer
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Endocrinology of the Aging Prostate: Current Concepts
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Diseases of the Canine Prostate Gland
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- O que sabemos sobre os inibidores da 5 alfa redutase?
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]